ACTIMED THERAPEUTICS LTD is a company based out of the United Kingdom.

Mankind Pharma

ACTIMED THERAPEUTICS

We’re supporting International Women and Girls in Science Day! 🔬
 
Join us in celebrating the incredible contributions of our talented female staff at Actimed, whose dedication and passion play a pivotal role in driving innovation.
 
We’re proud to be an inclusive and fair employer, and our phenomenal female staff shine in various roles across the company.
 
Here's to not only the women of Actimed, but all #WomenAndGirlsInScience!


Ahead of World Cancer Day, join us as we cast a light on cancer cachexia. For a long time, cachexia has been recognized as an adverse effect of cancer and it has been estimated that this devastating wasting disease affects 50–80% of cancer patients and accounts for up to 20% of cancer deaths. 
 
Other than supportive care, no globally approved products are available for this patient population so there remains an important unmet need for effective new treatments.
 
At Actimed, our work is rooted in our mission to bring innovation to the forefront of cancer cachexia treatment and redefine the standard of care for this under-served and vulnerable patient population.
 
Learn more about our work as we transform hope into action: actimedtherapeutics.com 
 
Learn more about #WorldCancerDay : www.worldcancerday.org
 
#CancerCachexia

We’re pleased to see Actimed featured in BioWorld following an interview by Caroline Richards with our CEO Robin Bhattacherjee. The article highlights our achievements in seeking to develop a treatment for cancer cachexia and outlines our further plans for our lead asset, s-pindolol benzoate, in the treatment of this devastating condition. 
 
For subscribers to BioWorld, read the article to learn more about our strides in advancing the fight against cancer cachexia: https://lnkd.in/ebGaJKiQ 

#CancerCachexia #BiotechFinancing #ClinicalDevelopment 

We are delighted to welcome Martin Walton as Chief Financial Officer at Actimed. 
 
Martin is a highly experienced advisor in the life sciences sector and has held a number of executive positions, completing transactions with over 25 companies and raising over £1bn in capital.
 
We believe Martin’s extensive experience and multidisciplinary skills set will play an important role in the continuing development of Actimed.

Medland Medical is a competitor in the field of regenerative medicine, focusing on innovative treatments for musculoskeletal diseases.

Medland Medical

Brexo Bio is a company specializing in regenerative medicine, with a focus on addressing unmet medical needs in orthopedics.

Brexo Bio

Regenerative is a competitor in the regenerative medicine industry, with a particular emphasis on developing therapies for tissue repair and regeneration in orthopedics.

Regenerative

Actimed Therapeutics is a biotechnology company focused on the discovery and development of innovative treatments for musculoskeletal diseases. The company leverages its expertise in the field of regenerative medicine to address the unmet medical needs in orthopedics, with a particular emphasis on developing therapies that promote the repair and regeneration of damaged tissues.

Actimed Therapeutics

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

news_advanced

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 16, 2024 9:25 AM	8710734f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
swot analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
customer profile	customers

COM:ACTIMEDTHERAPEUTICS

Actimed Therapeutics